Company / Operating Margin
Anika Therapeutics, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-9.8%
FY2025
5-year range
-21.7% / 29.9%
FY2021-FY2025
Trend
-130.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 10 years, ranging from -21.7% in FY2022 to 58.2% in FY2016.
Based on SEC 10-K filings.
-9.8% in FY2025 with a 5-year CAGR of -30.4%.
Declined from 0.7% to -9.8% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +11.9pp
- 5-Year Change
- -30.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 130.6% year-over-year.
- Peak operating margin was recorded in FY2016.
- Lowest operating margin in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -9.8% | -130.6% |
| FY2024 | -4.3% | -707.1% |
| FY2023 | 0.7% | +103.2% |
| FY2022 | -21.7% | -172.7% |
| FY2021 | 29.9% | +45.0% |
| FY2020 | 20.6% | -48.9% |
| FY2019 | 40.3% | -17.6% |
| FY2018 | 48.9% | -5.4% |
| FY2017 | 51.8% | -11.1% |
| FY2016 | 58.2% | +34.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026